Search Results - "Underhill, Kelly"

Patient and Dosimetric Predictors of Genitourinary and Bowel Quality of Life After Prostate SBRT: Secondary Analysis of a Multi-institutional Trial by Wang, Kyle, Chen, Ronald C., Kane, Brent L., Medbery, Clinton A., Underhill, Kelly J., Gray, James R., Peddada, Anuj V., Fuller, Donald B.

“…Stereotactic body radiation therapy (SBRT) is an emerging option for localized prostate cancer. However, there are no standard dosimetric guidelines, and…”
Get full text

Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes by Fuller, Donald B., Falchook, Aaron D., Crabtree, Tami, Kane, Brent L., Medbery, Clinton A., Underhill, Kelly, Gray, James R., Peddada, Anuj, Chen, Ronald C.

“…Stereotactic body radiation therapy is an emerging treatment for prostate cancer (PC), with potential biological and oncologic advantages. A well-established…”
Get full text

Increased Rates of Long-Term Complications after MammoSite Brachytherapy Compared with Whole Breast Radiation Therapy by Rosenkranz, Kari M., MD, Tsui, Edmund, BS, McCabe, Elizabeth B., MS, ARNP, Gui, Jiang, PhD, Underhill, Kelly, MD, Barth, Richard J., MD, FACS

“…Background Due to its short duration of therapy and low rates of local recurrence, women undergoing breast conservation are increasingly opting for partial…”
Get full text

The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905 by Lee, Larissa J, Ratner, Elena, Uduman, Mohamed, Winter, Kathryn, Boeke, Marta, Greven, Kathryn M, King, Stephanie, Burke, Thomas W, Underhill, Kelly, Kim, Harold, Boulware, Raleigh J, Yu, Herbert, Parkash, Vinita, Lu, Lingeng, Gaffney, David, Dicker, Adam P, Weidhaas, Joanne

“…To explore the association of a functional germline variant in the 3'-UTR of KRAS with endometrial cancer risk, as well as the association of microRNA (miRNA)…”
Get full text

Intensity-Modulated Radiotherapy for Head-and-Neck Cancer in the Community Setting by Seung, Steven, M.D., Ph.D, Bae, Joseph, B.S, Solhjem, Matthew, M.D, Bader, Stephen, M.D, Gannett, David, M.D, Hansen, Eric K., M.D, Louie, Jeannie, M.D, Underhill, Kelly, M.D, Cha, Christine, M.D

“…Purpose To review outcomes with intensity-modulated radiation therapy (IMRT) in the community setting for the treatment of nasopharyngeal and oropharyngeal…”
Get full text

Phase I Study of Topotecan and Radiation Therapy in Advanced Cervical Cancer by Dunton, Charles J., King, Stephanie A., Neufeld, Julia, Tolosa, Jorge, Perez, Gonzalo, Avila, Andres, Underhill, Kelly

“…Objective. The goal of this study was to determine the maximal tolerated dose (MTD) of topotecan given with external-beam radiotherapy in advanced cervical…”
Get full text

Final analysis of RTOG 9708: Adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer by Greven, Kathryn, Winter, Kathryn, Underhill, Kelly, Fontenesci, Jim, Cooper, Jay, Burke, Tom

“…A phase II study was completed by the RTOG to assess the feasibility, safety, toxicity, and patterns of recurrence and survival when chemotherapy was combined…”
Get full text

5-year outcomes from a prospective multi-institutional trial of heterogeneous dosing stereotactic body radiotherapy (SBRT) for low- and intermediate-risk prostate cancer by Fuller, Donald B., Kane, Brent L., Medbery, Clinton A., Underhill, Kelly, Gray, James R., Peddada, Anuj, Chen, Ronald C.

“…Abstract only 35 Background: SBRT is an emerging treatment for prostate cancer, but long-term reporting remains sparse. We present a prospective Phase II trial…”
Get full text

Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer by Greven, Kathryn, Winter, Kathryn, Underhill, Kelly, Fontenesci, Jim, Cooper, Jay, Burke, Tom

“…Patients with completely resected high-risk endometrial cancer have a risk of disease recurrence even with the addition of adjuvant pelvic radiotherapy (RT). A…”
Get more information

The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Trials 9708 and 9905: e94167 by Lee, Larissa J, Ratner, Elena, Uduman, Mohamed, Winter, Kathryn, Boeke, Marta, Greven, Kathryn M, King, Stephanie, Burke, Thomas W, Underhill, Kelly, Kim, Harold

“…Objective To explore the association of a functional germline variant in the 3'-UTR of KRAS with endometrial cancer risk, as well as the association of…”
Get full text

Treatment of head and neck cancer in patients with Fanconi's anemia by Goldstein, Stephen A, Keane, William M, Underhill, Kelly

Get full text